Trzeciak ER, Zimmer N, Gehringer I, Stein L, Graefen B, Schupp J, et al
Additionally, NRC-03 and NRC-07, two AMPs from the pleurocidins AMP family, exhibited equal killing effect at a concentration of 50M on normal MCF7 cells and on paclitaxel-resistant breast cancer cell line MCF7-TX400 that possess 2.6 times of P-gp expression more than the normal MCF7 cells, achieving about 60% of cell killing rate
Heparin II Domain of Fibronectin Uses Alpha4beta1 Integrin to Control Focal Adhesion and Stress Fiber Formation, Independent of Syndecan-4
The result is a measurable increase in skin firmness and elasticity
The skin is held taut, not pinched
In some embodiments, the otic formulation or composition comprises between about 0.001% to about 80% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof